News
![](https://opyl.ai/wp-content/uploads/2022/10/Untitled-design-5-392x286.png)
05/09/23
Opin.AI Breaks Down Barriers in Clinical Trial Participation
![](https://opyl.ai/wp-content/uploads/2023/05/Prepped-and-primed-2023-Opyl-392x286.jpg)
17/01/23
2023 Prepped and Primed: Opyl (ASX:OPL) with CEO, Michelle Gallaher
![](https://opyl.ai/wp-content/uploads/2022/12/2022-in-review-opyl-392x286.jpg)
07/12/22
Year in Review: Opyl (ASX:OPL) with CEO, Michelle Gallaher
![](https://opyl.ai/wp-content/uploads/2022/11/big_data_qantas_november_2022-392x286.jpg)
07/11/22
Big data could cure cancer
![](https://opyl.ai/wp-content/uploads/2023/05/Opyl-640x360-1-392x286.jpg)
21/10/22
Opyl’s TrialKey achieves major milestone with potential to improve clinical trial success rates
![](https://opyl.ai/wp-content/uploads/2022/10/1-darlinghurst-blog-post-image-20220923134602-392x286.webp)
30/09/22
Improving clinical trials with AI. Michelle Gallaher, Opyl.
![](https://opyl.ai/wp-content/uploads/2022/10/Opyl-28-Sep-2022.-Picture-Getty-1024x576-1-392x286.jpg)
28/09/22
Opyl tips revenue growth from partnership with Consentic and its newly launched screening services
![](https://opyl.ai/wp-content/uploads/2022/10/Opyl-pic-edited-1024x576-1-392x286.jpg)
16/09/22
Opyl appoints news chairman as it eyes international growth
![](https://opyl.ai/wp-content/uploads/2022/10/1-darlinghurst-blog-post-image-20220908090723.webp)
08/09/22
ANDHealth Summit 2022 – Technology as a Therapy
![](https://opyl.ai/wp-content/uploads/2022/10/Opyl-31-Aug-2022.-Picture-Getty-1024x576-1-392x286.jpg)
01/09/22
Opyl prepares to launch Opin into the global $4.7 billion clinical trial recruitment market
![](https://opyl.ai/wp-content/uploads/2022/10/race-e1659063566751-1024x576-1-392x286.jpg)
29/07/22
ASX Quarterlies: Tech powers ahead in strong finish to reporting week
![](https://opyl.ai/wp-content/uploads/2022/10/These-biotech-teams-are-getting-billions-of-funding-from-VCs.-Picture-Getty-Image-1024x576-1-392x286.jpg)
07/07/22